Figure 4

Spatial Analysis of Drug-Susceptible and Multidrug-Resistant Cases of Tuberculosis, Ho Chi Minh City, Vietnam, 2020–2023

Ruan Spies

, Hanh N. Hong, Phu P. Trieu, Luong K. Lan, Kim Lan, N.N. Hue, Nguyen T.L. Huong, Tran T.L.N. Thao, Nguyen L. Quang, Thu D.D. Anh, Truong V. Vinh, Dang T.M. Ha, Phan T. Dat, Nguyen P. Hai, Le H. Van, Guy E. Thwaites, Nguyen T.T. Thuong, James A. Watson¹, and Timothy M. Walker¹

Author affiliations: University of Oxford, Oxford, UK (R. Spies, G.E. Thwaites, N.T.T. Thuong, J.A. Watson, T.M. Walker); Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam (H.N. Hong, P.P. Trieu, L.K. Lan, K. Lan, N.N. Hue, N.T.L. Huong, T.L.T.N. Thao, N.L. Quang, T.D.D. Anh, L.H. Van, G.E. Thwaites, N.T.T. Thuong, J.A. Watson, T.M. Walker); Pham Ngoc Thach Hospital, Ho Chi Minh City (T.V. Vinh, D.T.M. Ha, P.T. Dat, N.P. Hai)

Main Article

Spatial clustering of drug-susceptible (A) and multidrug-resistant (B) tuberculosis incidence, Ho Chi Minh City, Vietnam, January 1, 2020–April 30, 2023, based on the Getis-Ord GI* statistic.

Figure 4. Spatial clustering of drug-susceptible (A) and multidrug-resistant (B) tuberculosis incidence, Ho Chi Minh City, Vietnam, January 1, 2020–April 30, 2023, based on the Getis-Ord GI* statistic.

Main Article

¹These authors contributed equally to this article.

Page created: December 10, 2023

Page updated: February 22, 2024

Page reviewed: February 22, 2024

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.